Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


30.10.2017

2 Anticancer Res
2 BMC Cancer
3 Br J Cancer
2 Cancer
2 Clin Cancer Res
20 Dis Esophagus
1 Gastrointest Endosc
1 J Clin Oncol
4 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. CHO JH, Joo YH, Shin EY, Park EJ, et al
    Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:6269-6280.
    PubMed     Text format     Abstract available

  2. LIU KC, Lin YJ, Hsiao YT, Lin ML, et al
    Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.
    Anticancer Res. 2017;37:6107-6118.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. MARITAZ C, Metz C, Baba-Hamed N, Jardin-Szucs M, et al
    Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
    BMC Cancer. 2016;16:384.
    PubMed     Text format     Abstract available

  4. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. PRAWIRA A, Oosting SF, Chen TW, Delos Santos KA, et al
    Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  6. KOSHIARIS C, Aveyard P, Oke J, Ryan R, et al
    Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  7. HALL SF, Liu FF, O'Sullivan B, Shi W, et al
    Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  8. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.
    PubMed     Text format    

  9. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.
    PubMed     Text format    


    Clin Cancer Res

  10. SHAYAN G, Kansy BA, Gibson SP, Srivastava RM, et al
    A Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.
    Clin Cancer Res. 2017 Oct 23. pii: clincanres.0357.2017.
    PubMed     Text format     Abstract available

  11. NIEHR F, Eder T, Pilz T, Konschak R, et al
    Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection.
    Clin Cancer Res. 2017 Oct 23. pii: clincanres.2410.2017.
    PubMed     Text format     Abstract available


    Dis Esophagus

  12. MANNER H, Wetzka J, May A, Pauthner M, et al
    Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Text format     Abstract available

  13. VAN ROSSUM PS, Haverkamp L, Carvello M, Ruurda JP, et al
    Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available

  14. VAN EGMOND MA, van der Schaaf M, Klinkenbijl JH, Engelbert RH, et al
    Preoperative functional status is not associated with postoperative surgical complications in low risk patients undergoing esophagectomy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available

  15. PARK A, Lee JH, Park A, Jung YH, et al
    Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available

  16. D'JOURNO XB, Berbis J, Jougon J, Brichon PY, et al
    External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available

  17. FUCHS HF, Harnsberger CR, Broderick RC, Chang DC, et al
    Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available

  18. CHEN H, Ni Z, Jing D, He L, et al
    Novel stent in the palliation of malignant esophageal strictures: a retrospective study.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available

  19. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available

  20. ZHAO J, Han Y, Lei J, Zhou Y, et al
    Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available

  21. KJAER DW, Nassar M, Jensen LS, Svendsen LB, et al
    A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available

  22. MURPHY CC, Yang YC, Shaheen NJ, Hofstetter WL, et al
    An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available

  23. ROSMOLEN WD, Nieuwkerk PT, Pouw RE, van Berge Henegouwen MI, et al
    Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available

  24. JANUSZEWICZ W, Kaminski MF, Wieszczy P, Wronska E, et al
    Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available

  25. GOENSE L, van Rossum PS, Tromp M, Joore HC, et al
    Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available

  26. SALEM AI, Thau MR, Strom TJ, Abbott AM, et al
    Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available

  27. WU HL, Guan BX, Liu B, Wang HJ, et al
    The intrapapillary capillary loop (IPCL) changes in superficial esophageal lesions.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available

  28. LINDNER K, Lubbe L, Muller AK, Palmes D, et al
    Potential risk factors and outcomes of fistulas between the upper intestinal tract and the airway following Ivor-Lewis esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available

  29. HAVERKAMP L, Seesing MF, Ruurda JP, Boone J, et al
    Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available

  30. PANTHAM G, Ganesan S, Einstadter D, Jin G, et al
    Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available

  31. MALIK V, Johnston C, O'Toole D, Lucey J, et al
    Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  32. SWAGER AF, Tearney GJ, Leggett CL, van Oijen MGH, et al
    Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett's esophagus using high-quality histological correlation.
    Gastrointest Endosc. 2017;85:918-926.
    PubMed     Text format     Abstract available


    J Clin Oncol

  33. CABANILLAS ME, de Souza JA, Geyer S, Wirth LJ, et al
    Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
    J Clin Oncol. 2017;35:3315-3321.
    PubMed     Text format     Abstract available


    PLoS One

  34. CASTAGNOLA P, Gandolfo S, Malacarne D, Aiello C, et al
    DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs.
    PLoS One. 2017;12:e0184425.
    PubMed     Text format     Abstract available

  35. SUMI M, Sato S, Nakamura T
    Extranodal spread of primary and secondary metastatic nodes: The dominant risk factor of survival in patients with head and neck squamous cell carcinoma.
    PLoS One. 2017;12:e0183611.
    PubMed     Text format     Abstract available

  36. WAN Z, Huang Z, Chen L
    Survival predictors associated with signet ring cell carcinoma of the esophagus (SRCCE): A population-based retrospective cohort study.
    PLoS One. 2017;12:e0181845.
    PubMed     Text format     Abstract available

  37. TAKENAKA Y, Kitamura T, Oya R, Ashida N, et al
    Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.
    PLoS One. 2017;12:e0181478.
    PubMed     Text format     Abstract available


    Radiother Oncol

  38. DE-COLLE C, Menegakis A, Monnich D, Welz S, et al
    SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
    Radiother Oncol. 2017 Oct 20. pii: S0167-8140(17)32648.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: